Notice of Results

RNS Number : 3924H

Instem plc

16 March 2015

 



16 March 2015

Instem plc
("Instem")

Notice of Results

Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, will announce preliminary results for the year ended 31 December 2014 on Monday 30 March 2015.

Management will be hosting a presentation for analysts on the day of the results at 9.30am at the offices of Walbrook PR, 4 Lombard Street, London, EC3V 9HD.

Analysts wishing to attend the presentation should register their interest by emailing [e-mail] or by telephoning 020 7933 8780.

For further information, please contact:

Instem plc	Tel: [phone]
Phil Reason, CEO	www.instem.com
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser & Broker)	Tel: [phone]
Richard Lindley
Nick Owen
Walbrook PR Ltd	Tel: [phone] or
Paul Cornelius	[e-mail]
Sam Allen
Helen Cresswell

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with an additional location in India and a full service distributor based in Japan.

To learn more about Instem solutions and its mission, please visit www.instem.com

 

END

 

 

NORDMGMFGFZGKZM